Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes-Reference-Cited by-同舟云学术

Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes

Published:2014-03-30 Issue:1 Volume:145 Page:137-142
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Jeong Young Jin,Kang Do-Young,Yoon Hyun Jin,Son Hye Joo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-2924-8.pdf

Reference19 articles.

1. Norum J, Andreassen T (2000) Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective? Anticancer Res 20:2193–2196

2. Kataja V, Castiglione M (2009) Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):10–14

3. Hegarty C, Collins CD (2010) PET/CT and breast cancer. Cancer Imaging 10:S59–S62

4. Choi YJ, Shin YD, Kang YH, Lee MS, Lee MK, Cho BS et al (2012) The effects of preoperative 18F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer 15:441–448

5. Lee JH (2013) Radionuclide methods for breast cancer staging. Semin Nucl Med 43:294–298

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of [18F]FDG PET/CT in patients with no special type breast cancer: Literature review and comparison between guidelines;The Breast;2024-09

2. Comparison of the Performance of [18F]-FDG PET/CT and [18F]-FDG PET/MRI for Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta- Analysis;Current Medical Imaging Reviews;2024-08-23

3. Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography);PET Clinics;2023-10

4. Imaging for Radiation Planning in Breast Cancer;Seminars in Nuclear Medicine;2022-09

5. FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer;Seminars in Nuclear Medicine;2022-09